Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indobufen vs Aspirin in CHD and GERD patients on DAPT
NCT04129008Phase 4Unknown
- Sponsor
- Beijing An Zhen Hospital
- Start
- Oct 2019
- Primary completion
- Sep 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Indobufen in coronary artery disease (CAD), sponsored by Beijing An Zhen Hospital. Status: unknown.
02
Drugs
Indobufen
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04129008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04129008.